These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 21218612)

  • 1. Five biomarkers from one cerebrospinal fluid sample to stage Alzheimer's disease.
    Nat Aging; 2024 May; 4(5):623-624. PubMed ID: 38594461
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer's disease diagnostic revolution.
    Schindler SE; Atri A
    Nat Aging; 2023 May; 3(5):460-462. PubMed ID: 37202514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscience enables ultrasensitive detection of Alzheimer's biomarker.
    Keating CD
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2263-4. PubMed ID: 15703290
    [No Abstract]   [Full Text] [Related]  

  • 4. Imaging and biomarkers will be used for detection and monitoring progression of early Alzheimer's disease.
    Weiner MW
    J Nutr Health Aging; 2009 Apr; 13(4):332. PubMed ID: 19300869
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting Driving Cessation in Alzheimer Disease: Performance Beats Biomarkers.
    Dubinsky RM; Stein AC
    Neurology; 2024 Jun; 102(12):e209523. PubMed ID: 38776521
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging the Alzheimer brain.
    Ashford JW; Salehi A; Furst A; Bayley P; Frisoni GB; Jack CR; Sabri O; Adamson MM; Coburn KL; Olichney J; Schuff N; Spielman D; Edland SD; Black S; Rosen A; Kennedy D; Weiner M; Perry G
    J Alzheimers Dis; 2011; 26 Suppl 3(0 3):1-27. PubMed ID: 21971448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances on biological markers in early diagnosis of Alzheimer disease.
    Padovani A; Borroni B; Di Luca M
    Adv Clin Chem; 2005; 39():107-29. PubMed ID: 16013669
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein.
    Marksteiner J; Hinterhuber H; Humpel C
    Drugs Today (Barc); 2007 Jun; 43(6):423-31. PubMed ID: 17612711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will CSF analysis become routine in people with memory complaints?
    Gauthier S
    Lancet Neurol; 2009 Jul; 8(7):595-6. PubMed ID: 19523878
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of cerebrospinal fluid biomarkers for diagnosis of incipient Alzheimer disease in patients with mild cognitive impairment.
    Dean RA; Shaw LM
    Clin Chem; 2010 Jan; 56(1):7-9. PubMed ID: 19926774
    [No Abstract]   [Full Text] [Related]  

  • 11. Biomarkers for the early diagnosis of Alzheimer's disease.
    de Leon MJ; Klunk W
    Lancet Neurol; 2006 Mar; 5(3):198-9. PubMed ID: 16488371
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neurochemical markers of neurodegeneration in the early diagnosis of Alzheimer's disease, vascular and mixed dementia].
    Uspenskaia OV; Iakhno NN; Belushkina NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):36-40. PubMed ID: 20823828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for Alzheimer's disease. The research advances incrementally, but clinical use is still years away.
    Harv Ment Health Lett; 2010 Nov; 27(5):1-3. PubMed ID: 21218612
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.